EXPLORING THE IMPACT OF ANEMIA AND CALCIUM IMBALANCE ON THE STAGES AND PROGRESSION OF CHRONIC KIDNEY DISEASE: A STUDY OF PATIENTS IN SOUTH PUNJAB, PAKISTAN
DOI:
https://doi.org/10.69723/njms.03.04.0443Abstract
BACKGROUND: Chronic kidney disease (CKD) poses a significant global health challenge, especially in developing regions such as South Punjab, where its prevalence is alarmingly high. Anemia and hypocalcaemia are common complications of CKD, yet their relationship with the disease severity remains poorly understood in this region. Globally, glomerulonephritis is a major cause of CKD, with particularly high prevalence in Asian countries. For instance, CKD affects approximately 10.6% of individuals in Nepal and up to 23.3% in Pakistan. Clinically, CKD is characterized by either kidney damage or a glomerular filtration rate (GFR) below 60 ml/min/1.73 m² sustained for over three months. Without proper treatment, CKD can advance to end-stage renal disease (ESRD) as kidney function continues to decline.
OBJECTIVE: This study aimed to explore the relationship between anemia and serum calcium levels with the severity and progression of chronic kidney disease (CKD) among patients in South Punjab.
METHODOLOGY: A cross-sectional study was performed at the Multan Institute of Kidney Diseases hospital in South Punjab, comprising 1, 437 male and 890 female patients with chronic kidney disease. Hemoglobin and serum calcium levels were measured and analyzed in relation to CKD stages, as defined by glomerular filtration rate (GFR).
CONCLUSION: The study revealed a significant inverse correlation between CKD severity and both hemoglobin and serum calcium levels. Patients with more advanced CKD stages exhibited greater anemia and hypocalcemia. These results indicate that hemoglobin and serum calcium levels could be useful biomarkers for CKD progression, which may aid in early detection and enhance management strategies in resource-limited settings.
KEYWORDS: CKD, Anemia, CA, HB, RF, Severity, Expansion, GFR.
References
Larkin H. WHO Report: Cholera Resurgent in 2022 After Years of Decline. JAMA. 2023;329(3):200. DOI: 10.1001/jama.2022.23551
Islam MT, Ross AG, Sleigh AC, Chowdhury F, Khan AI, McMillan NA, et al. A blueprint for eliminating cholera by 2030. Nat Med. 2022;28(9):1747–9. DOI: 10.1038/s41591-022-01898-w.
Malikzai A, Qamar K, Malik UU, Rafique F, Shaeen SK. Cholera spike following monsoon floods in Pakistan: Challenges, efforts and recommendations. Int J Surg Open. 2023;57:100652. • DOI: 10.1016/j.ijso.2023.100652.
Paye NG, Miller RHB, Zhou C, Weamie SJY, Davies TA. Systematic study and meta-analysis of risk factors associated with cholera outbreaks in africa: a review. Adv Infect Dis. 2021;11(2):240–60. DOI: 10.4236/aid.2021.112022.
Muzembo BA, Kitahara K, Debnath A, Ohno A, Okamoto K, Miyoshi S-I. Cholera outbreaks in India, 2011–2020: A systematic review. Int J Environ Res Public Health. 2022;19(9):5738. DOI: 10.3390/ijerph19095738.
Deen J, Mengel MA, Clemens JD. Epidemiology of cholera. Vaccine. 2020;38:A31–40. DOI: 10.1016/j.vaccine.2019.07.078.
Khan HA, Masood W, Siddiqui A, Ahmad S, Salman Y, Essar MY. The Cholera outbreak in Karachi, Pakistan: challenges, efforts and recommendations. Ann Med Surg. 2022;78:103873. DOI: 10.1016/j.amsu.2022.103873
Naveed A, Umer M, Ehsan M, Ayyan M, Shahid A, Zahid A, et al. The cholera outbreak in Lahore, Pakistan: challenges, efforts and recommendations. Trop Med Health. 2022;50(1):1–3. DOI: 10.1186/s41182-022-00458-9
Akram KS, Malik MW, Khan MA, Tahir MA, Adeel SS, Baig AM. Epidemiological Investigations of Acute Watery Diarrhea Outbreak During July-August 2017 in Amarpura, Rawalpindi - Pakistan. Pakistan J Public Heal. 2019;9(2):74–7. DOI: 10.32413/pjph.v9i2.204
Umair M, Khan M, Jabbar A, Khan SA, Hamayun M, Khan TA. Post-flood outbreaks of Cholera in Pakistan; Endemic-to-epidemic. J Infect Dev Ctries. 2023;17(03):423–4. DOI: 10.3855/jidc.17512
Pal BB, Khuntia HK, Nayak SR, Mohanty A, Biswal B. Vibrio cholerae O1 Ogawa strains carrying the ctxB7 allele caused a large cholera outbreak during 2014 in the tribal areas of Odisha, India. Jpn J Infect Dis. 2017;70(5):549–53. DOI: 10.7883/yoken.JJID.2016.585
Gwenzi W, Sanganyado E. Recurrent cholera outbreaks in sub-Saharan Africa: moving beyond epidemiology to understand the environmental reservoirs and drivers. challenges. 2019;10(1):1. https://doi.org/10.3390/challe10010001
Zerbo A, Delgado RC, González PA. A review of the risk of cholera outbreaks and urbanization in sub-Saharan Africa. J Biosaf Biosecurity. 2020;2(2):71–6. DOI:10.1016/j.jobb.2020.11.004
Elimian KO, Musah A, Mezue S, Oyebanji O, Yennan S, Jinadu A, et al. Descriptive epidemiology of cholera outbreak in Nigeria, January–November, 2018: implications for the global roadmap strategy. BMC Public Health. 2019;19(1):1–11. doi: 10.1186/s12889-019-7559-6.
Dinede G, Abagero A, Tolosa T. Cholera outbreak in Addis Ababa, Ethiopia: a case-control study. PLoS One. 2020;15(7):e0235440. DOI: 10.1371/journal.pone.0235440
Ocasio DV, Juin S, Berendes D, Heitzinger K, Prentice-Mott G, Desormeaux AM, et al. Cholera outbreak—Haiti, September 2022–January 2023. Morb Mortal Wkly Rep. 2023;72(2):21. DOI: 10.15585/mmwr.mm7202a1
Dureab F, Jahn A, Krisam J, Dureab A, Zain O, Al-Awlaqi S, et al. Risk factors associated with the recent cholera outbreak in Yemen: a case-control study. Epidemiol Health. 2019;41. DOI: 10.4178/epih.e2019015
Saha A, Rosewell A, Hayen A, MacIntyre CR, Qadri F. 2017. Improving immunization approaches to cholera. Expert Rev Vaccines 16:235–248. DOI: 10.1080/14760584.2017.1249470
Ilic I, Ilic M. Global patterns of trends in cholera mortality. Trop. med. infect.
Mar 13;8(3):169. DOI: 10.3390/tropicalmed8030169
Jubyda FT, Nahar KS, Barman I, Johura FT, Islam MT, Sultana M, Ullah W, Tasnim J, Biswas SR, Monir MM, George CM. Vibrio cholerae O1 associated with recent endemic cholera shows temporal changes in serotype, genotype, and drug-resistance patterns in Bangladesh. Gut Pathog.. 2023 Apr 12;15(1):17. DOI: 10.1186/s13099-023-00537-0
Junejo S, Shahid S, Khursheed N, Maqsood S, Adnan F, Khalid F. Cholera outbreak in 2022 among children in Karachi: Study of cases attending to a Tertiary Care Hospital. PaK J Med Sci. 2023 Sep;39(5):1496. DOI: https://doi.org/10.12669/pjms.39.5.7395
Gupta PK, Pant ND, Bhandari R, Shrestha P. Cholera outbreak caused by drug resistant Vibrio cholerae serogroup O1 biotype ElTor serotype Ogawa in Nepal; a cross-sectional study. Antimicrob. Resist. Infect. Control. 2016 Dec;5:1-5. DOI 10.1186/s13756-016-0122-7.
Luby SP, Davis J, Brown RR, Gorelick SM, Wong TH. Broad approaches to cholera control in Asia: Water, sanitation and handwashing. Vaccine. 2020 Feb 29;38:A110-7. DOI: 10.1016/j.vaccine.2019.07.084
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Sahrish Haji, Farrukh zia Tareen, Noor Muhammad, Nusrat Javed
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Readers may “Share-copy and redistribute the material in any medium or format” and “Adapt-remix, transform, and build upon the material”. The readers must give appropriate credit to the source of the material and indicate if changes were made to the material. Readers may not use the material for commercial purposes. The readers may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
.png)
